Keng‐Hsin Lan

4.9k citations

129 papers · 3.7k indexed · h-index 33

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Hepatology 43
- Hepatitis C virus research 32
- Hepatocellular Carcinoma Treatment and Prognosis 10
Biotechnology 12
- Cancer Research and Treatments 11

Co-authors: Masao Omata (16 shared papers)Yasushi Shiratori (12 shared papers)Naoya Kato (8 shared papers)Ono S (6 shared papers)Meei‐Ling Sheu (10 shared papers)Richard R. Neubig (6 shared papers)Shou‐Dong Lee (18 shared papers)Yee Chao (22 shared papers)
Journals: PLoS ONE (6 papers)Cancers (4 papers)Hepatology (4 papers)Oncotarget (4 papers)Archives of Biochemistry and Biophysics (3 papers)
Partner nations: Taiwan United States Japan

In The Last Decade

Keng‐Hsin Lan

123 papers receiving 3.6k citations

Peers

Countries citing papers authored by Keng‐Hsin Lan

Since Specialization

Citations

This map shows the geographic impact of Keng‐Hsin Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keng‐Hsin Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keng‐Hsin Lan more than expected).

Fields of papers citing papers by Keng‐Hsin Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keng‐Hsin Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keng‐Hsin Lan. The network helps show where Keng‐Hsin Lan may publish in the future.

Co-authors

The 25 scholars most cited alongside Keng‐Hsin Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keng‐Hsin Lan Line = papers co-authored together Keng‐Hsin Lan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis Oncogene ·Keng‐Hsin Lan, Meei‐Ling Sheu, Shinn‐Jang Hwang, Sang‐Hue Yen, Shiow‐Yi Chen, Jaw‐Ching Wu, Yuan-Jan Wang, Naoya Kato, Masao Omata, Full‐Young Chang, Shou‐Dong Lee	2002	186
2	Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer Hepatology ·Naoya Kato, Hideo Yoshida, Ono S, Jun Kato, Tadashi Goto, Motoyuki Otsuka, Keng‐Hsin Lan, Kouji Matsushima, Yasushi Shiratori, Masao Omata	2000	167
3	A Point Mutation in Gαo and Gαi1Blocks Interaction with Regulator of G Protein Signaling Proteins Journal of Biological Chemistry ·Keng‐Hsin Lan, Noune A. Sarvazyan, Ronald Taussig, Robert G. MacKenzie, Paul R. DiBello, Henrik Dohlman, Richard R. Neubig	1998	149
4	In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. PubMed ·Fumihiko Kanai, Keng‐Hsin Lan, Yasushi Shiratori, Toshihiro Tanaka, Makoto Ohashi, T Okudaira, Yoko Yoshida, Hiroaki Wakimoto, Hirohumi Hamada, Hidekazu Nakabayashi, T Tamaoki, Masao Omata	1997	141
5	Ymdd Motif in Hepatitis B Virus Dna Polymerase Influences on Replication and Lamivudine Resistance: A Study By In Vitro Full–Length Viral Dna Transfection Hepatology ·Ono S, Naoya Kato, Yasushi Shiratori, Tsutomu Masaki, Keng‐Hsin Lan, Flair José Carrilho, Masao Omata	1999	138
6	Hepatitis C Virus Core Protein Enhances p53 Function through Augmentation of DNA Binding Affinity and Transcriptional Ability Journal of Biological Chemistry ·Motoyuki Otsuka, Naoya Kato, Keng‐Hsin Lan, Hideo Yoshida, Jun Kato, Tadashi Goto, Yasushi Shiratori, Masao Omata	2000	138
7	The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population Clinical Cancer Research ·Wei-Ping Lee, Dar‐In Tai, Keng‐Hsin Lan, Anna Fen–Yau Li, Hou-Ching Hsu, En-Ju D. Lin, Yi-Ping Lin, Meei‐Ling Sheu, Chung‐Pin Li, Full-Young Chang, Yee Chao, Shang-Heu Yen, Shou‐Dong Lee	2005	133
8	Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator Journal of Virology ·Nobuyuki Kato, Keng‐Hsin Lan, Ono S, Yasushi Shiratori, Masao Omata	1997	126
9	Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors Journal of Clinical Investigation ·Ono S, Naoya Kato, Yasushi Shiratori, Keng‐Hsin Lan, Hideo Yoshida, Flair José Carrilho, Masao Omata	1999	104
10	Gene Therapy for α–Fetoprotein–Producing Human Hepatoma Cells by Adenovirus–Mediated Transfer of the Herpes Simplex Virus Thymidine Kinase Gene Hepatology ·Fumihiko Kanai, Yasushi Shiratori, Yoko Yoshida, Hiroaki Wakimoto, Hirotaka Hamada, Yumi Kanegae, I. Saito, Hidekazu Nakabayashi, T Tamaoki, Toshihiro Tanaka, Keng‐Hsin Lan, Naoya Kato, Shuichiro Shiina, Masao Omata	1996	101
11	Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma Cancers ·Pei‐Chang Lee, Yee Chao, Ming‐Huang Chen, Keng‐Hsin Lan, Chieh-Ju Lee, I‐Cheng Lee, San‐Chi Chen, Ming‐Chih Hou, Yi‐Hsiang Huang	2020	86
12	Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. PubMed ·Toshihiro Tanaka, Fumihiko Kanai, Shigeo Okabe, Yoko Yoshida, Hiroaki Wakimoto, Hirofumi Hamada, Yoshimune Shiratori, Keng‐Hsin Lan, M Ishitobi, Masao Omata	1996	85
13	Inverse Association between Hepatitis B Virus Infection and Fatty Liver Disease: A Large-Scale Study in Populations Seeking for Check-Up PLoS ONE ·Yuan-Lung Cheng, Yuan-Jen Wang, Wei‐Yu Kao, Ping-Hsien Chen, Teh‐Ia Huo, Yi‐Hsiang Huang, Keng‐Hsin Lan, Chien‐Wei Su, Wan‐Leong Chan, Han‐Chieh Lin, Fa‐Yauh Lee, Jaw‐Ching Wu	2013	80
14	Rapid Kinetics of Regulator of G-protein Signaling (RGS)-mediated Gαi and Gαo Deactivation Journal of Biological Chemistry ·Keng‐Hsin Lan, Huailing Zhong, Masakatsu Nanamori, Richard R. Neubig	2000	79
15	Integrative Functional Genomics of Hepatitis C Virus Infection Identifies Host Dependencies in Complete Viral Replication Cycle PLoS Pathogens ·Qisheng Li, Yong-Yuan Zhang, Stephan Chiu, Zongyi Hu, Keng‐Hsin Lan, Helen Cha, Catherine Sodroski, Fang Zhang, Ching-Sheng Hsu, Emmanuel Thomas, T. Jake Liang	2014	76
16	Strategies to target HER2/neu overexpression for cancer therapy Drug Resistance Updates ·Jin‐Shing Chen, Keng‐Hsin Lan, Mien‐Chie Hung	2003	70
17	Honokiol Induces Calpain-Mediated Glucose-Regulated Protein-94 Cleavage and Apoptosis in Human Gastric Cancer Cells and Reduces Tumor Growth PLoS ONE ·Meei‐Ling Sheu, Shing‐Hwa Liu, Keng‐Hsin Lan	2007	67
18	In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. PubMed ·Keng‐Hsin Lan, F Kanai, Yoshimune Shiratori, Makoto Ohashi, Toshihiro Tanaka, T Okudaira, Yoko Yoshida, Hirohumi Hamada, Masao Omata	1997	59
19	G_iActivator Region of α_2A-Adrenergic Receptors: Distinct Basic Residues Mediate G_iversus G_sActivation Molecular Pharmacology ·Susan M. Wade, William K. Lim, Keng‐Hsin Lan, Duane A. Chung, Masakatsu Nanamori, Richard R. Neubig	1999	56
20	Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectors Gastroenterology ·Keng‐Hsin Lan, Fumihiko Kanai, Yasushi Shiratori, Shigeo Okabe, Yoko Yoshida, Hiroaki Wakimoto, Hirotaka Hamada, Toshihiro Tanaka, Makoto Ohashi, Masao Omata	1996	54

About Keng‐Hsin Lan

Keng‐Hsin Lan is a scholar working on Hepatology, Biotechnology, Oncology, Epidemiology and Radiation, having authored 129 papers that have together received 3.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (32 papers), Hepatitis B Virus Studies (24 papers), Liver Disease Diagnosis and Treatment (16 papers), Cancer Research and Treatments (11 papers), Virus-based gene therapy research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Advanced Radiotherapy Techniques (7 papers) and HIV/AIDS drug development and treatment (7 papers). The work is most often cited by research in Hepatology (1.2k citations), Epidemiology (1.1k citations), Biotechnology (241 citations), Oncology (753 citations) and Immunology (502 citations). Keng‐Hsin Lan has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Masao Omata, Yasushi Shiratori, Naoya Kato, Ono S, Meei‐Ling Sheu, Richard R. Neubig, Shou‐Dong Lee, Yee Chao, Hideo Yoshida and Yi‐Hsiang Huang. Their work appears in journals such as PLoS ONE, Cancers, Hepatology, Oncotarget and Archives of Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact